RU95107063A - Medicinal agent for treatment of infectious disease in animals and methods of treatment of infectious disease in animals - Google Patents

Abstract

FIELD: veterinary science agent. SUBSTANCE: agent has the following ratio of components, wt.-%: rifampicin 0.9-1.1; polymixin M sulfate 0.9-1.1; native aubasidan 17.5-22.5; nipagin 0.1-0.15; citric acid 1.0-1.2; sodium hydroxide 0.3-0.35, and water - the rest. Optimal ratio of active components is, wt. -%: rifampycin 1.0, and polymixin M sulfate 1.0. Agent can be used for treatment of gastroenteric disease in animals and preferable doses (by oral administration) are - 1 ml/kg animal mass, twice per a day for 2-4 days. Agent can be used for treatment of gynecological disease in cows and preferable doses (by intrauterine administration) are - 200-300 ml per dose, once during 2-3 days. EFFECT: enhanced therapeutic activity, broad spectrum of curative action.

Claims (1)

The invention relates to veterinary medicine, in particular to drugs used to treat infectious diseases. The proposed drug has a wide range of applications and a range of therapeutic effects, as well as increased therapeutic effectiveness and can be prepared in the form of a composition with the following ratio of components: rifampicin 0.9 - 1.1, polymyxin M sulfate 0.9 - 1.1, aubazidan native 17.5 - 22.5, nipagin 0.1 - 0.15, citric acid 1, 0 - 1, 2, caustic soda 0.3 - 0.35, the rest is water. In this case, the optimum ratio of active components is, wt. %: rifampicin 1.0, polymyxin M sulfate 1.0. The drug can be used to treat gastrointestinal diseases in animals, with doses of 1 ml / kg of animal weight 2 times a day for 2-4 days being preferred (when administered orally). The drug can be used to treat gynecological diseases of cows, with doses of 200-300 ml per administration once every 2 to 3 days are preferred (with intrauterine administration).